Infliximab and Ulcerative Colitis

Ulcerative colitis (UC) is one of the main forms of inflammatory bowel disease. The condition causes the colon and rectum to become inflamed and ulcerated.

Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study

How to Manage Ulcerative Colitis and Diabetes

Immunomodulator Withdrawal From Anti-TNF Therapy Is Not Associated With Loss of Response in Inflammatory Bowel Disease - ScienceDirect

PDF) Ulcerative Colitis and Acute Severe Ulcerative Colitis Patients Are Overlooked in Infliximab Population Pharmacokinetic Models: Results from a Comprehensive Review

Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan, BMC Pediatrics

Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis - ScienceDirect

Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis

What is Infliximab (Remicade)?

Figure 4 from Emerging Treatment Options in Mild to Moderate Ulcerative Colitis.

Remicade (infliximab) FDA Approval History

Infliximab and Ulcerative Colitis

Biologics: Matching Drugs to Patients

Ulcerative colitis - The Lancet

Ulcerative colitis - AGA GI Patient Center

Ulcerative colitis: MedlinePlus Genetics

Is Ulcerative Colitis Curable?: Digestive Disease Specialists

Manual Of Medicine on X: Ulcerative Colitis vs Crohn's Disease by @stephaneebeggs #foamed #medtwitter #meded / X

Ulcerative Colitis Cypress TX Ulcerative Colitis Surgery Tomball, Spring TX